购物车
全部删除
您的购物车当前为空
CDK8-IN-13是一种 CDK8抑制剂(IC50:51.9 nM),具有强效性、选择性和口服活性。CDK8-IN-13能诱导细胞凋亡,降低了 p-STAT1 S727和p-STAT5 S726的表达。CDK8-IN-13表现出抗肿瘤活性。


为众多的药物研发团队赋能,
让新药发现更简单!
CDK8-IN-13是一种 CDK8抑制剂(IC50:51.9 nM),具有强效性、选择性和口服活性。CDK8-IN-13能诱导细胞凋亡,降低了 p-STAT1 S727和p-STAT5 S726的表达。CDK8-IN-13表现出抗肿瘤活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 233 | 现货 | |
| 5 mg | ¥ 538 | 现货 | |
| 10 mg | ¥ 787 | 现货 | |
| 25 mg | ¥ 1,320 | 现货 | |
| 50 mg | ¥ 1,990 | 现货 | |
| 100 mg | ¥ 2,880 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 518 | 现货 |
CDK8-IN-13 相关产品
| 产品描述 | CDK8-IN-13 is a CDK8 inhibitor (IC50: 51.9 nM) with potent, selective and oral activity. CDK8-IN-13 induces apoptosis and reduces the expression of p-STAT1 S727 and p-STAT5 S726. CDK8-IN-13 exhibits anti-tumour activity. |
| 靶点活性 | CDK8:51.9 nM |
| 体外活性 | CDK8-IN-13在HCT-116细胞中以剂量依赖性降低了p-STAT1 S727和p-STAT5 S726的表达。[1] CDK8-IN-13(0、1、5、10 µM;48小时)以剂量依赖性诱导凋亡。[1] |
| 体内活性 | CDK8-IN-13(40, 80 mg/kg;口服;持续15天)在小鼠中通过剂量依赖的方式抑制肿瘤生长。[1] |
| 分子量 | 237.26 |
| 分子式 | C14H11N3O |
| CAS No. | 918523-75-8 |
| Smiles | C(N)(=O)C=1C=C(C=2C=C3C(=NC2)NC=C3)C=CC1 |
| 密度 | 1.324 g/cm3 at 20℃ (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 112.5 mg/mL (474.2 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容